تحميل...
Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors: AN INTEGRATED STRATEGY FOR THE DEVELOPMENT OF NEW ANTIANGIOGENIC COMPOUNDS
Endogenous inhibitors of angiogenesis, such as thrombospondin-1 (TSP-1), are promising sources of therapeutic agents to treat angiogenesis-driven diseases, including cancer. TSP-1 regulates angiogenesis through different mechanisms, including binding and sequestration of the angiogenic factor fibrob...
محفوظ في:
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , |
---|---|
التنسيق: | Artigo |
اللغة: | Inglês |
منشور في: |
American Society for Biochemistry and Molecular Biology
2010
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2838296/ https://ncbi.nlm.nih.gov/pubmed/20056600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M109.085605 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|